The genus erythrovirus

Parvoviruses

Volumn , Issue , 2005, Pages 25-45

  Brown, Kevin E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54249096633     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (150)

1. Agbandje, M., McKenna, R., Rossmann, M. G. et al. 1991. Preliminary X-ray crystallographic investigation of human parvovirus B19. Virology 184: 170-4.
2. Agbandje, M., McKenna, R., Rossmann, M. G. et al. 1993. Structure determination of feline panleukopenia virus empty particles. Proteins 16: 155-71.
3. Allander, T., Emerson, S. U., Engle, R. E. et al. 2001. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proceedings of the National Academy of Science USA 98: 11609-14.
4. Anderson, M. J., Jones, S. E., Fisher-Hoch, S. P. et al. 1983. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet I: 1378.
5. Astell, C. R., Mol, C. D. and Anderson, W. F. 1987. Structural and functional homology of parvovirus and papovavirus polypeptides. Journal of General Virology 68: 885-93.
6. Astell, C. R., Luo, W., Brunstein, J. and St Amand, J.1997. B19 parvovirus: biochemical an molecular features. In: Anderson, L. J. and Young, N. S. Human parvovirus B19. Monographs in Virology. Basel: Karger. Parks, W. P. Volume 1(20), pp. 16-41.
7. Bansal, G. P., Hatfield, J. A., Dunn, F. E. et al. 1993. Candidate recombinant vaccine for human B19 parvovirus. Journal of Infectious Diseases 167: 1034-44.
8. Beard, C., St Amand, J. and Astell, C. R. 1989. Transient expression of B19 parvovirus gene products in COS-7 cells transfected with B19-SV40 hybrid vectors. Virology 172: 659-64.
9. Blumel, J., Schmidt, I., Effenberger, W. etal. 2002a. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42: 1473-81.
10. Blumel, J., Schmidt, I., Willkommen, H. and Lower, J. 2002. Inactivation of parvovirus B19 during pasteurization of human serum albumin. Transfusion 42: 1011-18.
11. Blundell, M. C., Beard, C. and Astell, C. R. 1987. In vitro identification of a B19 parvovirus promoter. Virology 157: 534-8.
12. Blundell, M. C. and Astell, C. R. 1989. A GC-box motif upstream of the B19 parvovirus unique promoter is important for in vitro transcription. Journal of Virology 63. 4814-23.
13. Bostic, J. R., Brown, K. E., Young, N. S. and Koenig, S. 1999. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase- polymerase chain reaction-based assay. Journal of Infectious Diseases 179: 619-26.
14. Brown, K. E. and Cohen, B. J. 1992. Haemagglutination by parvovirus B19. Journal of General Virology 73: 2147-9.
15. Brown, K. E. and Young, N. S.1997 Human parvovirus B19: pathogenesis of disease. In: Anderson, L. J. and Young, N. S. Human parvovirus B19. Monographs in Virology. Basel: Karger. Parks, W. P. Volume 1(20), pp. 105-19.
16. Brown, C. S., Van Lent, J. W., Vlak, J. M. and Spaan, W. J. 1991a. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. Journal of Virology 65: 2702-6.
17. Brown, K. E., Mori, J., Cohen, B. J. and Field, A. M. 1991b. In vitro propagation of parvovirus B19 in primary foetal liver culture. Journal of General Virology 72: 741-5.
18. Brown, K. E., Anderson, S. M. and Young, N. S. 1993. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262: 114-17.
19. Brown, K. E., Green, S. W., Antunez de Mayolo, J. et al. 1994a. Congenital anaemia after transplacental B19 parvovirus infection. Lancet343: 895-6.
20. Brown, K. E., Hibbs, J. R., Gallinella, G. et al. 1994b. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). New England Journal of Medicine 330: 1192-6.
21. Brown, K. E., Young, N. S. and Liu, J. M. 1994c. Molecular, cellular and clinical aspects of parvovirus B19. Critical Reviews in Oncology/Hematology 16: 1-31.
22. Brown, K. E., Green, S. W., Kajigaya, S., O'Sullivan, M. G. and Young, N. S. 1995a. Simian parvoviruses-new members of the Erythrovirus genus. VIth Parvovirus Workshop, Montpellier, France, S7 #6.
23. Brown, K. E., Green, S. W., O'Sullivan, M. G. and Young, N. S. 1995b. Cloning and sequencing of the simian parvovirus genome. Virology 210: 314-22.
24. Brown, K. E., Liu, Z., Gallinella, G., Wong, S., Mills, I. P. and O'Sullivan, M. G. 2004. Simian parvovirus infection: a potential zoonosis. Journal of Infectious Diseases 190: 1900-7.
25. Brunstein, J., Soderlund-Venermo, M. and Hedman, K. 2000. Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19. Virology 274: 284-91.
26. Caillet-Fauquet, P., Perros, M., Brandenburger, A. et al. 1990. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO Journal 9: 2989-95.
27. Carter, B. J. and Flotte, T. R. 1996. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis. Current Topics in Microbiology and Immunology 218: 119-44.
28. Chipman, P. R., Agbandje-McKenna, M., Kajigaya, S. et al. 1996. Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proceedings of the National Academy of Science USA 93: 7502-6.
29. Choi, C. S., Molitor, T. W. and Joo, H. S. 1987. Inhibition of porcine parvovirus replication by empty virus particles. Archives of Virology 96: 75-87.
30. Clewley, J. P. 1984. Biochemical characterization of a human parvovirus. Journal of General Virology 65: 241-5.
31. Clewley, J. P. 1985. Detection of human parvovirus using a molecularly cloned probe. Journal ofMedical Virology 15: 173-81.
32. Cohen, B. J. and Brown, K. E. 1992. Laboratory infection with human parvovirus B19. Journal ofInfection 24: 113-14.
33. Cooling, L. L., Zhang, d. S., Naides, S. J. and Koerner, T. A. 2003. Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts. Blood 101: 711-21.
34. Cossart, Y. E., Field, A. M., Cant, B. and Widdows, D. 1975. Parvovirus- like particles in human sera. Lancet I: 72-73.
35. Cotmore, S. F. and Tattersall, P. 1984. Characterization and molecular cloning of a human parvovirus genome, Science 226: 1161-65.
36. Cotmore, S. F., McKie, V. C., Anderson, L. J. et al. 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. Journal of Virology 60: 548-57.
37. Deiss, V., Tratschin, J. D., Weitz, M. and Siegl, G. 1990. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology 175: 247-54.
38. Doerig, C., Beard, P. and Hirt, B. 1987. A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo. Virology 157: 539-42.
39. Doerig, C., Hirt, B., Antonietti, J. P. and Beard, P. 1990. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. Journal of Virology 64: 387-96.
40. Dorsch, S., Kaufmann, B., Schaible, U. et al. 2001. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability. Journal of General Virology 82: 191-9.
41. Dorsch, S., Liebisch, G., Kaufmann, B. et al. 2002. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. Journal ofVirology 76: 2014-18.
42. Erdman, D. D., Durigon, E. L., Wang, Q.-Y. and Anderson, L. J. 1996. Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates. Journal of General Virology 77: 2767-74.
43. Fan, M. M., Tamburic, L., Shippam-Brett, C. et al. 2001. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner. Virology 291: 285-91.
44. Foresman, L., Narayan, O. and Pinson, D. 1999. Progressive anemia in a pig-tail macaque with AIDS. Contemporary Topics in Laboratory Animal Science 38: 20-2.
45. Frickhofen, N. and Young, N. S. 1989. Persistent parvovirus B19 infections in humans. Microbial Pathogenesis 7: 319-27.
46. Fu, Y., Ishii, K. K., Munakata, Y. et al. 2002. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. Journal ofVirology 76: 5395-403.
47. Gallinella, G., Anderson, S. M., Young, N. S. and Brown, K. E. 1995. Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture. Journal ofVirology 69: 3897-9.
48. Gareus, R., Gigler, A., Hemauer, A. etal. 1998. Characterization of cis- acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19. Journal ofVirology 72: 609-16.
49. Green, S. W., Malkovska, I., O'Sullivan, M. G. and Brown, K. E. 2000. Rhesus and pig-tailed macaque parvoviruses: identification of two new members of the Erythrovirus genus in monkeys. Virology 269: 105-12.
50. Guillot, M., Lefrere, J. J., Ravenet, N. et al. 1987. Acute anaemia and aplastic crisis without haemolysis in human parvovirus infection. Journal ofClinical Pathology 40: 1264-5.
51. Heegaard, E. D., Qvortrup, K. and Christensen, J. 2002. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. Journal of Medical Virology 66: 246-52.
52. Hemauer, A., von Poblotzki, A., Gigler, A. et al. 1996. Sequence variability among different parvovirus B19 isolates. Journal of General Virology 77: 1781-5.
53. Henrickson, R. V., Maul, D. H., Lerche, N. W. et al. 1984. Clinical feature of simian acquired immunodeficiency syndrome (SAIDS) in rhesus monkeys. LaboratoryAnimal Science 34: 140-5.
54. Hijikata, M., Abe, K., Win, K. M. et al. 2001. Identification of new parvovirus DNA sequence in swine sera from Myanmar. Japan Journal ofInfectectious Diseases 54: 244-5.
55. Hokynar, K., Soderlund-Venermo, M., Pesonen, M. et al. 2002. A new parvovirus genotype persistent in human skin. Virology 302: 224-8.
56. James, J. A., Escalante, C. R., Yoon-Robarts, M. et al. 2003. Crystal structure of the SF3 helicase from adeno-associated virus type 2. Structure (Camb.) 11: 1025-35.
57. Joag, S. V., Li, L., Foresman, L. et al. 1997. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Research and Human Retroviruses 13: 635-45.
58. Jordan, J. A. and DeLoia, J. A. 1999. Globoside expression within the human placenta. Placenta 20: 103-8.
59. Kajigaya, S., Shimada, T., Fujita, S. and Young, N. S. 1989. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proceedings of the National Academy of Science USA 86: 7601-5.
60. Kajigaya, S., Fujii, H., Field, A. et al. 1991. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proceedings of the National Academy of Science USA 88: 4646-50.
61. Kaludov, N., Padron, E., Govindasamy, L. et al. 2003. Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4. Virology 306: 1-6.
62. Leruez, M., Pallier, C., Vassias, I. et al. 1994. Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization. Journal of General Virology 75: 1475-8.
63. Leruez-Ville, M., Vassias, I., Pallier, C. et al. 1997. Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter. Journal of General Virology 78: 215-19.
64. Liu, J. M., Fujii, H., Green, S. W. et al. 1991a. Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells. Virology 182: 361-4.
65. Liu, J. M., Green, S. W., Hao, Y. S. et al. 1991b. Upstream sequences within the terminal hairpin positively regulate the P6 promoter of B19 parvovirus. Virology 185: 39-47.
66. Liu, J. M., Green, S. W., Shimada, T. and Young, N. S. 1992. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. Journal ofVirology 66: 4686-92.
67. Liu, Z., Qiu, J., Cheng, F., Chu, Y. et al. 2004. Comparison of the transcription profile of simian parvovirus with that of the human erythrovirus B19 reveals a number of unique features. Journal of Virology 78: 12929-39.
68. Luo, W. and Astell, C. R. 1993. A novel protein encoded by small RNAs of parvovirus B19. Virology 195: 448-55.
69. MacKenzie, M., Lowenstein, L., Lalchandani, R. et al. 1986. Hematologic abnormalities in simian acquired immune deficiency syndrome. Laboratory Animal Science 36: 14-19.
70. McKenna, R., Olson, N. H., Chipman, P. R. et al. 1999. Three- dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. Journal ofVirology 73: 6882-91.
71. Mills, I. P., Basu, A. and Brown, K. E. 2002. Expression of simian parvovirus capsid proteins in insect cells. American Society of Virology 21st Annual Meeting, P32-2.
72. Miyagawa, E., Yoshida, T., Takahashi, H. et al. 1999. Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. Journal ofVirology Methods 83: 45-54.
73. Moffatt, S., Tanaka, N., Tada, K. et al. 1996. A cytotoxic non- structural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. Journal of Virology 70: 8485-91.
74. Moffatt, S., Yaegashi, N., Tada, K. et al. 1998. Human parvovirus B19 non-structural (NS1) protein induces apoptosis in erythroid lineage cells. Journal ofVirology 72: 3018-28.
75. Momoeda, M., Kawase, M., Jane, S. M. et al. 1994. The transcriptional regulator YY1 binds to the 5'-terminal region of B19 parvovirus and regulates P6 promoter activity. Journal of Virology 68: 7159-68.
76. Momoeda, M., Wong, S., Kawase, M. et al. 1994. A putative nucleoside triphosphate-binding domain in the non-structural protein of B19 parvovirus is required for cytotoxicity. Journal of Virology 68: 8443-6.
77. Morey, A. L. and Fleming, K. A. 1992. Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro. British JournalofHaematology 82: 302-9.
78. Mori, J., Beattie, P., Melton, D. W. et al. 1987. Structure and mapping of the DNA of human parvovirus B19. Journal of General Virology 68: 2797-806.
79. Morinet, F., Tratschin, J. D., Perol, Y. and Siegl, G. 1986. Comparison of 17 isolates of the human parvovirus B19 by restriction enzyme analysis. Brief report. Archives ofVirology 90: 165-72.
80. Morinet, F., D'Auriol, L., Tratschin, J. D. and Galibert, F. 1989. Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera. Journal of General Virology 70: 3091-7.
81. Morita, E., Nakashima, A., Asao, H. et al. 2003. Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase. Journal ofVirology 77: 2915-21.
82. Morita, E., Tada, K., Chisaka, H. et al. 2001. Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins. Journal ofVirology 75: 7555-63.
83. Mortimer, P. P., Humphries, R. K., Moore, J. G. etal. 1983. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302: 426-9.
84. Munshi, N. C., Zhou, S., Woody, M. J. et al. 1993. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. Journal of Virology 67: 562-6.
85. Nguyen, Q. T., Sifer, C., Schneider, V. et al. 1998. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet352: 1524.
86. Nguyen, Q. T., Sifer, C., Schneider, V. et al. 1999. Novel human erythrovirus associated with transient aplastic anemia. Journal of Clinical Microbiology 37: 2483-7.
87. Nguyen, Q. T., Wong, S., Heegaard, E. D. and Brown, K. E. 2002. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301: 374-80.
88. O'Sullivan, M. G., Anderson, D. C., Fikes, J. D. et al. 1994. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia: a paradigm of human B19 parvovirus infection. Journal ofClinical Investigation 93: 1571-6.
89. O'Sullivan, M. G., Anderson, D. K., Lund, J. E. et al. 1996. Clinical and epidemiological features of simian parvovirus infection in cynomolgus macaques with severe anemia. Laboratory Animal Science 46: 291-7.
90. Okochi, K., Mori, R., Miyazaki, M. et al. 1984. Nakatani antigen and human parvovirus (B19). Lancet i: 160-1.
91. Ozawa, K. and Young, N. 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. Journal ofVirology 61: 2627-30.
92. Ozawa, K., Kurtzman, G. and Young, N. 1986. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233: 883-6.
93. Ozawa, K., Ayub, J., Hao, Y. S. et al. 1987a. Novel transcription map for the B19 (human) pathogenic parvovirus. Journal ofVirology 61: 2395-406.
94. Ozawa, K., Kurtzman, G. and Young, N. 1987b. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70: 384-91.
95. Ozawa, K., Ayub, J., Kajigaya, S. et al. 1988a. The gene encoding the non-structural protein of B19 (human) parvovirus may be lethal in transfected cells. Journal ofVirology 62: 2884-9.
96. Ozawa, K., Ayub, J. and Young, N. 1988 b. Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets. Journal ofBiological Chemistry 263: 10922-6.
97. Page, R. D.M. 1996. TREEVIEW: An application to display phylogenetic trees on personal computers. Computer Applications in the Biosciences 12: 357-8.
98. Paradiso, P. R. 1981. Infectious process of the parvovirus H-1: correlation of protein content, particle density and viral infectivity. Journal ofVirology 39: 800-7.
99. Pattison, J. R., Jones, S. E., Hodgson, J. et al. 1981. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet i: 664-5.
100. Pillet, S., Annan, Z., Fichelson, S. and Morinet, F. 2003. Identification of a nonconventional motif necessary for the nuclear import of the human parvovirus B19 major capsid protein (VP2). Virology 306: 25-32.
101. Raab, U., Bauer, B., Gigler, A. et al. 2001. Cellular transcription factors that interact with p6 promoter elements of parvovirus B19. Journal of General Virology 82: 1473-80.
102. Raab, U., Beckenlehner, K., Lowin, T. et al. 2002. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3. Virology 293: 86-93.
103. Rayment, F. B., Crosdale, E., Morris, D. J. et al. 1990. The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. Journal of General Virology 71: 2665-72.
104. Rosenfeld, S. J., Yoshimoto, K., Kajigaya, S. et al. 1992. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. Journal ofClinical Investigation 89: 2023-9.
105. Rouger, P., Gane, P. and Salmon, C. 1987. Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies. Revue Française de Transfusion et Immuno- hématologie 30: 699-708.
106. Sadahira, Y., Sugihara, T. and Yawata, Y. 2001. Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection. International Journal of Hematology 74: 147-52.
107. Saikawa, T., Anderson, S., Momoeda, M. et al. 1993. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1- VP2 junction regions. Journal ofVirology 67: 3004-9.
108. Saito, T., Munakata, Y., Fu, Y. et al. 2003. Evaluation of antiparvovirus B19 activity in sera by assay using quantitative polymerase chain reaction. Journal of Virological Methods 107: 81-7.
109. Serke, S., Schwarz, T. F., Baurmann, H. et al. 1991. Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization. British Journal of Haematology 79: 6-13.
110. Servant, A., Laperche, S., Lallemand, F. et al. 2002. Genetic diversity within human erythroviruses: identification of three genotypes. Journal ofVirology 76: 9124-34.
111. Shade, R. O., Blundell, M. C., Cotmore, S. F. et al. 1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. Journal ofVirology 58: 921-36.
112. Shimomura, S., Komatsu, N., Frickhofen, N. et al. 1992. First continuous propagation of B19 parvovirus in a cell line. Blood 79: 18-24.
113. Shimomura, S., Wong, S., Brown, K. E. et al. 1993. Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology 194: 149-56.
114. Shneerson, J. M., Mortimer, P. P. and Vandervelde, E. M. 1980. Febrile illness due to a parvovirus. British MedicalJournal 280: 1580.
115. Siegl, G., Bates, R. C., Berns, K. I. et al. 1985. Characteristics and taxonomy of Parvoviridae. Intervirology 23: 61-73.
116. Sisk, W. P. and Berman, M. L. 1987. Expression of human parvovirus B19 structural protein in E. coli and detection of antiviral antibodies in human serum. Bio/Technology 5: 1077-80.
117. Sol, N., Le Junter, J., Vassias, I. et al. 1999. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. Journal ofVirology 73: 8762-70.
118. Spalholz, B. A. and Tattersall, P. 1983. Interaction of minute virus of mice with differentiated cells: strain-dependent target cell specificity is mediated by intracellular factors. Journal ofVirology 46: 937-43.
119. Srivastava, A. and Lu, L. 1988. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. Journal of Virology 62: 3059-63.
120. Srivastava, A., Bruno, E., Briddell, R. etal. 1990. Parvovirus B19- induced perturbation of human megakaryocytopoiesis in vitro. Blood 76: 1997-2004.
121. St Amand, J. and Astell, C. R. 1993. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology 192: 121-31.
122. St Amand, J., Beard, C., Humphries, K. and Astell, C. R. 1991. Analysis of splice junctions and in vitro and in vivo translation potential of the small, abundant B19 parvovirus RNAs. Virology 183: 133-42.
123. Summers, J., Jones, S. E. and Anderson, M. J. 1983. Characterization of the genome of the agent erythocyte aplasia permits its classification as a human parvovirus. Journal of General Virology 64: 2527-32.
124. Takahashi, T., Ozawa, K., Mitani, K. et al. 1989. B19 parvovirus replicates in erythroid leukemic cells in vitro. Journal of Infectious Diseases 160: 548-9.
125. Takahashi, T., Ozawa, K., Takahashi, K. et al. 1990. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75: 603-10.
126. Tattersall, P. and Cotmore, S. F. 1988. The nature of parvoviruses. In: Pattison, J. R. (ed.), Parvoviruses and human disease. Boca Raton, Fl: GRC press, pp. 5-41.
127. Tsao, J., Chapman, M. S., Agbandje, M. et al. 1991. The three- dimensional structure of canine parvovirus and its functional implications. Science 251: 1456-64.
128. Uemura, N., Ozawa, K., Tani, K. et al. 1995. Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient. European Journal ofHaematology 54: 68-9.
129. Umene, K. and Nunoue, T. 1990. The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: a correlation between genome type and prevalence. Journal of General Virology 71: 983-6.
130. Van Horn, D. K., Mortimer, P. P., Young, N. and Hanson, G. R. 1986. Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia. American Journal of Pediatrics and Hematology/Oncology 8: 235-9.
131. Vashisht, K., Faaberg, K. S., Aber, A. L., Brown, K. E. and O'Sullivan, M. G. 2004. Splice junction map of simian parvovirus transcripts. Journal ofVirology 87: 10911-19.
132. Vassias, I., Hazan, U., Michel, Y. et al. 1998. Regulation of human B19 parvovirus promoter expression by hGABP (E4TF1) transcription factor. Journal of Biological Chemistry 273: 8287-93.
133. von dem Borne, A. E., Bos, M. J., Joustra-Maas, N. et al. 1986. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). British Journal ofHaematology 63: 35-46.
134. Watanabe, M., Ringler, D. J., Nakamura, M. et al. 1990. Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth. Journal ofVirology 64: 656-63.
135. Weigel-Kelley, K. A., Yoder, M. C. and Srivastava, A. 2001. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. Journal ofVirology 75: 4110-16.
136. Weigel-Kelley, K. A., Yoder, M. C. and Srivastava, A. 2003. a5p1 integrin as a cellular co-receptor for human parvovirus B19: requirement of functional activation of p1 integrin for viral entry, Blood 103: 3927-33.
137. Wiels, J., Mangeney, M., Tétaud, C. and Tursz, T. 1991. Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiation. International Immunology 3: 1289-300.
138. Wong, S. and Brown, K. 2003. Comparison of parvovirus B19 infection in cell lines. American Society of Virology, 22nd Annual Meeting, W26-2.
139. Wong, S., Young, N. S. and Brown, K. E. 2003. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. Journal of Infectious Diseases 187: 1581-6.
140. Wong, S., Momoeda, M., Field, A. et al. 1994. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein. Journal ofVirology 68: 4690-4.
141. Xie, Q., Somasundaram, T., Bhatia, S. et al. 2003. Structure determination of adeno-associated virus 2: three complete virus particles per asymmetric unit. Acta Crystallographica D. Biological Crystallography 59: 959-70.
142. Yaegashi, N., Shiraishi, H., Takeshita, T. et al. 1989. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. Journal ofVirology 63: 2422-6.
143. Yamano, H., Nakade, T., Ogawa, H. et al. 1980. An unidentified antigen-antibody system, Nakatani, detected by immunoelectrosyneresis. Blood Programme 3: 275-9.
144. Yoo, B. C., Park, S. M., Kim, C. Y. et al. 1988. A virus similar to human hepatitis B virus in Manchurian chipmunks. Korean Journal of Internal Medicine 3: 102-9.
145. Yoo, B. C., Lee, D. H., Park, S. M. et al. 1999. A novel parvovirus isolated from Manchurian chipmunks. Virology 253: 250-8.
146. Young, N., Harrison, M., Moore, J. et al. 1984. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. Journal ofClinical Investigation 74: 2024-32.
147. Yunoki, M., Tsujikawa, M., Urayama, T. et al. 2003. Heat sensitivity of human parvovirus B19. VoxSanguis 85: 67-8.
148. Zadori, Z., Szelei, J., Lacoste, M. C. et al. 2001. A viral phospholipase A2 is required for parvovirus infectivity. Developmental Cell 1: 291-302.
149. Zhi, N., Zadori, Z., Brown, K. E. and Tijssen, P. 2004. Construction and sequencing of an infectious clone of the human parvovirus, B19. Virology 318: 142-52.
150. Zuccheri, G., Bergia, A., Gallinella, G. et al. 2001. Scanning force microscopy study on a single-stranded DNA: the genome of parvovirus B19. Chembiochemistry 2: 199-204.